Literature DB >> 3018289

Cell receptors for the mammalian reovirus: reovirus-specific T-cell hybridomas can become persistently infected and undergo autoimmune stimulation.

N Matsuzaki, V S Hinshaw, B N Fields, M I Greene.   

Abstract

We have previously described the development of virus-specific helper T cell hybridomas which recognize structural determinants shared by type 1 and type 3 reoviruses that have been exposed to UV radiation. We have found that T-cell hybridomas become persistently infected with live type 3 reovirus used for the immunization. Persistently infected T-hybridoma cells were found to spontaneously produce interleukin 2 (IL-2). To analyze the mechanism of induction of IL-2 secretion of persistently infected T-cell hybridomas, we exposed T-cell hybridomas specific for UV-treated virus to replicating type 3 reovirus. The T-cell hybridomas became infected but did not produce IL-2 unless simultaneously exposed to syngeneic I-A+ antigen-presenting cells. In this situation, the persistently infected T-cell hybridomas produced IL-2 without being reexposed to virus. This process was not a consequence of nonspecific IL-2 gene activation, which occurs in cells persistently infected with reovirus, because reovirus infection did not activate IL-2 secretion in T-cell hybridomas with other antigenic specificities. Reovirus exposure also resulted in persistent infection of certain antigen-presenting B-cell tumor lines. The persistently infected B-cell tumor lines could stimulate reovirus-specific helper T cells but not T-cell hybridomas of other specificities. The data support the thesis that persistent infection of reovirus-specific T cells creates a mechanism in which the virus released from these cells is processed and then reexpressed by I-A+ antigen-presenting cells. The IA antigen and reovirus structures on the antigen-presenting cells then restimulate the T cells through their specific receptors, resulting in IL-2 synthesis and release. These observations may be relevant to mechanisms of autoimmunity induced by virus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018289      PMCID: PMC253924     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Structural similarities between the mammalian beta-adrenergic and reovirus type 3 receptors.

Authors:  M S Co; G N Gaulton; A Tominaga; C J Homcy; B N Fields; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

2.  Cell receptors for the mammalian reovirus. II. Monoclonal anti-idiotypic antibody blocks viral binding to cells.

Authors:  R S Kauffman; J H Noseworthy; J T Nepom; R Finberg; B N Fields; M I Greene
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

3.  Topological analysis of the reovirus type 3 hemagglutinin.

Authors:  D R Spriggs; K Kaye; B N Fields
Journal:  Virology       Date:  1983-05       Impact factor: 3.616

4.  Identification of idiotypic receptors on reovirus-specific cytolytic T cells.

Authors:  H C Ertl; M I Greene; J H Noseworthy; B N Fields; J T Nepom; D R Spriggs; R W Finberg
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

5.  Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin 2 receptor-ligand complex.

Authors:  T R Malek; R J Robb; E M Shevach
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

6.  An IL 2-secreting T cell hybridoma that responds to a self class I histocompatibility antigen in the H-2D region.

Authors:  R O Endres; P Marrack; J W Kappler
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

7.  Cell receptors for the mammalian reovirus. I. Syngeneic monoclonal anti-idiotypic antibody identifies a cell surface receptor for reovirus.

Authors:  J H Noseworthy; B N Fields; M A Dichter; C Sobotka; E Pizer; L L Perry; J T Nepom; M I Greene
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

8.  Failure of regulation of Tac antigen/TCGF receptor on adult T-cell leukemia cells by anti-Tac monoclonal antibody.

Authors:  M Tsudo; T Uchiyama; H Uchino; J Yodoi
Journal:  Blood       Date:  1983-05       Impact factor: 22.113

9.  Serologic and functional characterization of a panel of antigen-presenting cell lines expressing mutant I-A class II molecules.

Authors:  L H Glimcher; S O Sharrow; W E Paul
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

10.  The role of Ia molecules in the activation of T lymphocytes. III. Antigen-specific, Ia-restricted, interleukin 2-producing T cell hybridomas with detectable affinity for the restricting I-A molecule.

Authors:  K L Rock; B Benacerraf
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

View more
  3 in total

1.  Efficiency of viral entry determines the capacity of murine erythroleukemia cells to support persistent infections by mammalian reoviruses.

Authors:  J D Wetzel; J D Chappell; A B Fogo; T S Dermody
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

Review 2.  The antigen-major histocompatibility complex-T cell receptor interaction. A structural analysis.

Authors:  W V Williams; D B Weiner; S Wadsworth; M I Greene
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

3.  Immunotherapeutic strategies targeting rheumatoid synovial T-cell receptors by DNA inoculation.

Authors:  W V Williams; Q Fang; J M Von Feldt; J D Boyer; M Luchi; B Wang; D B Weiner
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.